APA (7th ed.) Citation

O, d. D., MA, R., I, G., B, S., J, M., D, M., . . . P, S. (2024). NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. Journal for immunotherapy of cancer, 12(8), . https://doi.org/10.1136/jitc-2024-009210

Chicago Style (17th ed.) Citation

O, de Dios, et al. "NKG2C/KLRC2 Tumor Cell Expression Enhances Immunotherapeutic Efficacy Against Glioblastoma." Journal for Immunotherapy of Cancer 12, no. 8 (2024). https://doi.org/10.1136/jitc-2024-009210.

MLA (9th ed.) Citation

O, de Dios, et al. "NKG2C/KLRC2 Tumor Cell Expression Enhances Immunotherapeutic Efficacy Against Glioblastoma." Journal for Immunotherapy of Cancer, vol. 12, no. 8, 2024, https://doi.org/10.1136/jitc-2024-009210.